prostate tumor tissue
-
not specified
RNA-seq; Microarray; Clinical Sample Validation; Survival Analysis; ROC Analysis
downregulated in MPC vs. LPC; part of a validated 5-circRNA prognostic signature for BCR
circZNF532 is down-regulated in metastatic versus localized prostate cancer and is included in a validated 5-circRNA signature predicting BCR after surgery. No mechanistic role is tested.
0.5202
The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer.
combined biological and clinical study